RDHL Projected Dividend Yield
Level 2 Sponsored ADR Par/Redhill Biopharma Ltd, Ramat Gan ( NASDAQ : RDHL )RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company focused on gastrointestinal and infectious diseases. It markets drugs like Talicia for Helicobacter pylori infections and Aemcolo for travelers' diarrhea. The company is advancing several late-stage clinical programs, including RHB-204 for pulmonary nontuberculous mycobacteria, opaganib (ABC294640), a host-directed SPHK2 inhibitor, and RHB-107 (upamostat) for non-hospitalized symptomatic COVID-19. Additionally, it is developing RHB-104 for Crohn's disease and RHB-102 for nausea and vomiting related to chemotherapy and radiotherapy, aiming to address significant medical needs. 21 YEAR PERFORMANCE RESULTS |
RDHL Dividend History Detail RDHL Dividend News RDHL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |